A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/26/2009	WO2009113810A3 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases
11/26/2009	WO2009111315A9 Methods for reducing granulomatous inflammation
11/26/2009	WO2009102473A3 Human g-protein chemokine receptor (ccr5) hdgnr10
11/26/2009	WO2009093007A3 Immune modulation by regioselectively modified glycosides
11/26/2009	WO2009082664A3 Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof
11/26/2009	WO2009074867A3 Analysis of mixtures including proteins
11/26/2009	WO2008108830A8 Immunogenic and therapeutic compositions for streptococcus pyogenes
11/26/2009	US20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/26/2009	US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/26/2009	US20090292007 Inhibition of TACE or amphiregulin for the Modulation of EGF Receptor Signal Transactivation
11/26/2009	US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009	US20090291498 Biodegradable T-cell activation method
11/26/2009	US20090291493 Human immunodeficiency virus-neutralizing antibodies with improved breadth and potency
11/26/2009	US20090291460 Assay for transmissible spongiform encephalopathies
11/26/2009	US20090291144 Therapeutic and Prophylactic Compositions Including Catalytic Biomimetic Solids and Methods to Prepare and Use Them
11/26/2009	US20090291139 Sparc and methods of use thereof
11/26/2009	US20090291103 Quality control methods for oil-in-water emulsions containing squalene
11/26/2009	US20090291099 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
11/26/2009	US20090291098 Immunogenic LHRH compositions and methods relating thereto
11/26/2009	US20090291097 IL-17 homologous polypeptides and therapeutic uses thereof
11/26/2009	US20090291096 Methods and Apparatus for Selectively Processing Eggs Having Identified Characteristics
11/26/2009	US20090291095 Nanoemulsion adjuvants
11/26/2009	US20090291094 Antibodies and processes for preparing the same
11/26/2009	US20090291093 Immunoconjugates with an Intracellularly-Cleavable Linkage
11/26/2009	US20090291092 Treatment of mitochondrial diseases with an erythropoietin mimetic
11/26/2009	US20090291091 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases
11/26/2009	US20090291090 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
11/26/2009	US20090291089 Antagonists of IL-6 to prevent or treat Thrombosis
11/26/2009	US20090291088 Therapeutic combinations of anti-igf-1r antibodies and other compounds
11/26/2009	US20090291087 Modulating angiogenesis
11/26/2009	US20090291086 Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
11/26/2009	US20090291085 Human estrogen receptor specific immunoglobulin for use in treatment and prevention of cell proliferative disorders
11/26/2009	US20090291084 Anti- il-6 antibodies, compositions, methods and uses
11/26/2009	US20090291083 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same
11/26/2009	US20090291082 Antagonists of IL-6 to raise Albumin and/or lower CRP
11/26/2009	US20090291081 Dual-specific IL-1A/IL-1b antibodies
11/26/2009	US20090291080 Levels of april in serum and use in diagnostic methods
11/26/2009	US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
11/26/2009	US20090291078 Glyco-engineered antibodies
11/26/2009	US20090291077 Antagonists of IL-6 to prevent or treat Cachexia, weakness, fatigue, and/or fever
11/26/2009	US20090291076 Stabilized antibody-containing formulations
11/26/2009	US20090291075 Binding agents and their use in targeting tumor cells
11/26/2009	US20090291074 Mutations in oas1 genes
11/26/2009	US20090291073 Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
11/26/2009	US20090291072 Means and methods for the treatment of tumorous diseases
11/26/2009	US20090291070 Biologically Active Silver-Coated Proteins
11/26/2009	US20090291062 Protein formulations and methods of making same
11/26/2009	US20090291048 Leukocyte-binding polypeptides and uses thereof
11/26/2009	US20090291047 Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
11/26/2009	CA2826508A1 Nanoemulsion vaccines
11/26/2009	CA2725534A1 Inhibition of emmprin to treat multiple sclerosis
11/26/2009	CA2725526A1 Anti-tumoral cells
11/26/2009	CA2725329A1 Nanoemulsion vaccines
11/26/2009	CA2725169A1 Method of generating single vl domain antibodies in transgenic animals
11/26/2009	CA2725162A1 An adapter molecule for the delivery of adenovirus vectors
11/26/2009	CA2724886A1 Methods, compositions and apparatuses for facilitating regeneration
11/26/2009	CA2724782A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	CA2724649A1 Compositions comprising prfa* mutant listeria and methods of use thereof
11/26/2009	CA2724570A1 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
11/26/2009	CA2718918A1 Methods for treating or preventing colorectal cancer
11/26/2009	CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology
11/25/2009	EP2123677A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
11/25/2009	EP2123676A1 Diagnosis and treatment of cancer by using anti-prg-3 antibody
11/25/2009	EP2123675A2 Human EPO mimentic hinge core mimetibodies, compositions, methods and uses
11/25/2009	EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2123671A1 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
11/25/2009	EP2123668A1 Immunogenic polypeptides that mimic the surface polysaccharide O-antigen from serotype 2A shigella flexneri, method for obtaining the same, and their use in vaccine and diagnostic compositions
11/25/2009	EP2123302A1 Chronic rejection inhibitor
11/25/2009	EP2123300A1 Medicinal agent for treating bird flu
11/25/2009	EP2123299A1 Therapeutic agent for interstitial pulmonary disease comprising anti-hmgb-1 antibody
11/25/2009	EP2123298A1 Agent for suppressing rejection in organ transplantation comprising anti-hmgb-1 antibody
11/25/2009	EP2123297A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
11/25/2009	EP2123296A1 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same
11/25/2009	EP2123261A1 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
11/25/2009	EP2121762A1 BINDING MEMBERS FOR IgE MOLECULES
11/25/2009	EP2121760A2 Antibodies to cd200r
11/25/2009	EP2121758A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists
11/25/2009	EP2121756A1 Antibodies and methods for making and using them
11/25/2009	EP2121755A1 Antibodies specific for dkk-1
11/25/2009	EP2121754A1 Pegylated a fab
11/25/2009	EP2121751A2 Monoclonal antibodies against angptl3
11/25/2009	EP2121732A1 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles
11/25/2009	EP2121731A1 Peptide vaccines for cancers expressing tumor-associated antigens
11/25/2009	EP2121057A1 Polymerization with precipitation of proteins for elution in physiological solution
11/25/2009	EP2121019A1 A new immunoglobulin against helicobacter pylori
11/25/2009	EP2121017A2 Method for inhibiting the expression of endogenous erythropoietin (epo)
11/25/2009	EP2121015A2 Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts
11/25/2009	EP2121014A2 Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
11/25/2009	EP2121012A2 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
11/25/2009	EP2121011A2 Vaccines including antigen from four strains of influenza virus
11/25/2009	EP2121009A1 Francisella strain for live vaccine
11/25/2009	EP2121008A2 Uses of monoclonal antibody 8h9
11/25/2009	EP2120996A2 Methods for using and identifying modulators of delta-like 4
11/25/2009	EP2120992A1 Use of platelet glycopeptide iiia epitopes in the treatment of immune thrombocytopenic purpura
11/25/2009	EP2120975A1 Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments
11/25/2009	EP1861420B1 Fermentation process for the production of diphtheria toxin
11/25/2009	EP1545594B1 Bacteriophage-mediated immunisation against hepatitis
11/25/2009	EP1458853B1 Methods of donor specific crossmatching
11/25/2009	EP1325033B1 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection

1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 1823